OTTAWA, Ontario--(BUSINESS WIRE)--On behalf of the Board of Directors of BIOTECanada, Chairman Oliver Technow is pleased to announce the appointment of Wendy Zatylny as the incoming President & CEO of BIOTECanada, representing the biotechnology ecosystem in Canada.
With extensive leadership experience and a strong commitment to innovation, Zatylny will guide the association through a period of unprecedented competition and growth in the sector. Zatylny will begin her role on January 13th representing BIOTECanada, and host meetings with members at the JP Morgan Healthcare Conference and Biotech showcase events in San Francisco.
“We are pleased to welcome Wendy to BIOTECanada,” stated Oliver Technow. “Her experience in leading a national industry association equips her with valuable insights and expertise that will drive BIOTECanada’s ongoing growth and success. Her leadership will be instrumental in strengthening collaboration across the sector and advancing policies that position Canada’s biotechnology ecosystem as a global leader."
Zatylny brings extensive leadership experience across key sectors of the Canadian economy, including life sciences, logistics, telecommunications, and marine transportation. Her roles with Rx&D, the Association of Canadian Port Authorities, and SBA Communications have equipped her with a strong understanding of industrial and sectoral development on global levels. With expertise in corporate affairs and association management, she is well-prepared to advance BIOTECanada’s mission and support growth in the biotechnology sector.
This transition marks a significant milestone for BIOTECanada as the association continues to champion Canadian biotechnology on the national and global stage. BIOTECanada looks forward to ongoing collaboration with its members, stakeholders, and partners, building on the momentum of recent achievements and driving the sector toward future success.
BIOTECanada is the national industry association voice. With over 230 member companies, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges. Visit: biotech.ca
